{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Impact of Diabetes Mellitus on Left Ventricular Assist Device Outcomes: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "The sample size was calculated to detect a 1% difference in hemoglobin A1c levels with 80% power."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants included patients with advanced HF eligible for LVAD implantation."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received standard LVAD therapy, while the control group received LVAD therapy with additional DM management."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aims to elucidate the impact of DM on LVAD outcomes."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in hemoglobin A1c levels over 12 months."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, with allocation concealment ensured by sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised, with 100 in each group, between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted using an intention-to-treat approach, with 98 participants in the intervention group and 97 in the control group."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group showed a significant decrease in A1c levels (mean difference = 1.2%, 95% CI 0.8 to 1.6; p < 0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were more frequent in the control group, with 10% experiencing major infections compared to 5% in the intervention group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678"
      },
      "Funding": {
        "score": 1,
        "evidence": "This study was funded by the National Institutes of Health."
      }
    },
    "total_score": 23,
    "max_score": 25
  },
  "model": "gpt-4o"
}